Literature DB >> 27499982

Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients.

Matteo Pozzi1, Carlo Banfi2, Daniel Grinberg1, Catherine Koffel3, Karim Bendjelid4, Jacques Robin1, Raphaël Giraud4, Jean François Obadia1.   

Abstract

Myocarditis is an inflammatory disease of the heart muscle with established histological, immunological and immunohistochemical diagnostic criteria. Different triggers could be advocated as possible etiologies of myocarditis such as viral and non-viral infections, medications, systemic autoimmune diseases and toxic reactions. The spectrum of clinical presentations of myocarditis is broad and varies from subclinical asymptomatic courses to refractory cardiogenic shock. The prognosis of patients with myocarditis depends mainly on the severity of clinical presentation. In particular, myocarditis patients developing cardiogenic shock refractory to optimal maximal medical treatment may benefit from the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a temporary mechanical circulatory support (MCS). The aim of the present report is to offer a review of the most important articles of the literature showing the results of VA-ECMO in the specific setting of cardiogenic shock due to myocarditis in adult patients.

Entities:  

Keywords:  Myocarditis; cardiogenic shock; extracorporeal membrane oxygenation (ECMO)

Year:  2016        PMID: 27499982      PMCID: PMC4958873          DOI: 10.21037/jtd.2016.06.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  42 in total

1.  National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee).

Authors:  Naoyoshi Aoyama; Tohru Izumi; Katsuhiko Hiramori; Mitsuaki Isobe; Masatoshi Kawana; Michiaki Hiroe; Hitoshi Hishida; Yasushi Kitaura; Tsutomu Imaizumi
Journal:  Circ J       Date:  2002-02       Impact factor: 2.993

2.  The Fourth INTERMACS Annual Report: 4,000 implants and counting.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2012-02       Impact factor: 10.247

3.  Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first?

Authors:  Yih-Sharng Chen; Hsi-Yu Yu; Shu-Chien Huang; Kaung-Ming Chiu; Tzu-Yu Lin; Lin-Ping Lai; Fang-Yue Lin; Shoei-Shan Wang; Shu-Hsun Chu; Wen-Je Ko
Journal:  J Heart Lung Transplant       Date:  2005-01       Impact factor: 10.247

4.  Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock.

Authors:  Charles-Edouard Luyt; Antoine Landivier; Pascal Leprince; Maguy Bernard; Alain Pavie; Jean Chastre; Alain Combes
Journal:  J Crit Care       Date:  2012-03-02       Impact factor: 3.425

5.  Percutaneous balloon atrioseptostomy for left heart discharge in extracorporeal life support patients with persistent pulmonary edema.

Authors:  Mathieu Bignon; Vincent Roule; Ziad Dahdouh; Rémi Sabatier; Thérèse Lognoné; Guillaume Malcor; Moussa Idali; Calin Ivascau; Massimo Massetti; Gilles Grollier
Journal:  J Interv Cardiol       Date:  2011-11-04       Impact factor: 2.279

Review 6.  Myocarditis.

Authors:  Sandeep Sagar; Peter P Liu; Leslie T Cooper
Journal:  Lancet       Date:  2011-12-18       Impact factor: 79.321

7.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

8.  Percutaneous Decompression of the Left Ventricle in Cardiogenic Shock Patients on Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Mohamad Alkhouli; Craig R Narins; Juan Lehoux; Peter A Knight; Bryan Waits; Frederick S Ling
Journal:  J Card Surg       Date:  2016-01-25       Impact factor: 1.620

Review 9.  Hemodynamics of Mechanical Circulatory Support.

Authors:  Daniel Burkhoff; Gabriel Sayer; Darshan Doshi; Nir Uriel
Journal:  J Am Coll Cardiol       Date:  2015-12-15       Impact factor: 24.094

10.  Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients.

Authors:  Richard Cheng; Rory Hachamovitch; Michelle Kittleson; Jignesh Patel; Francisco Arabia; Jaime Moriguchi; Fardad Esmailian; Babak Azarbal
Journal:  J Card Fail       Date:  2014-03-15       Impact factor: 5.712

View more
  7 in total

Review 1.  Veno-arterial extracorporeal membrane oxygenation: an overview of different cannulation techniques.

Authors:  Carlo Banfi; Matteo Pozzi; Marie-Eve Brunner; Fabio Rigamonti; Nicolas Murith; Damiano Mugnai; Jean-Francois Obadia; Karim Bendjelid; Raphaël Giraud
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  The Surgeon's Role in Cardiogenic Shock.

Authors:  Alexandra E Sperry; Matthew Williams; Pavan Atluri; Wilson Y Szeto; Marisa Cevasco; Christian A Bermudez; Michael A Acker; Michael Ibrahim
Journal:  Curr Heart Fail Rep       Date:  2021-05-06

Review 3.  Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis.

Authors:  Daowen Wang; Sheng Li; Jiangang Jiang; Jiangtao Yan; Chunxia Zhao; Yan Wang; Yexin Ma; Hesong Zeng; Xiaomei Guo; Hong Wang; Jiarong Tang; Houjuan Zuo; Li Lin; Guanglin Cui
Journal:  Sci China Life Sci       Date:  2018-12-03       Impact factor: 6.038

4.  Associations with the In-Hospital Survival Following Extracorporeal Membrane Oxygenation in Adult Acute Fulminant Myocarditis.

Authors:  Shaur-Zheng Chong; Chih-Yuan Fang; Hsiu-Yu Fang; Huang-Chung Chen; Chien-Jen Chen; Cheng-Hsu Yang; Chi-Ling Hang; Hon-Kan Yip; Chiung-Jen Wu; Wei-Chieh Lee
Journal:  J Clin Med       Date:  2018-11-20       Impact factor: 4.241

5.  Successful treatment of fulminant myocarditis with intra-aortic balloon pump counterpulsation combined with immunoglobulin and glucocorticoid in a young male adult.

Authors:  Huanhuan Li; Lun Li
Journal:  Front Cardiovasc Med       Date:  2022-07-22

Review 6.  Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors.

Authors:  Filio Billia; Ana Carolina Alba; Julie K K Vishram-Nielsen; Farid Foroutan; Saima Rizwan; Serena S Peck; Julia Bodack; Ani Orchanian-Cheff; Finn Gustafsson; Heather J Ross; Eddy Fan; Vivek Rao
Journal:  Heart Fail Rev       Date:  2022-10-07       Impact factor: 4.654

7.  Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation.

Authors:  Min Li; Si-Chao Gu; Xiao-Jing Wu; Jin-Gen Xia; Yi Zhang; Qing-Yuan Zhan
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.